2023 - Research.com Medicine in Belgium Leader Award
His Disease study frequently draws connections to other fields, such as Neurodegeneration. His research on Neurodegeneration frequently connects to adjacent areas such as Disease. He integrates Internal medicine with Intensive care medicine in his research. In his research, Sebastiaan Engelborghs undertakes multidisciplinary study on Intensive care medicine and Internal medicine. He brings together Pathology and Oncology to produce work in his papers. His work often combines Oncology and Pathology studies. He undertakes multidisciplinary studies into Dementia and Alzheimer's disease in his work. He carries out multidisciplinary research, doing studies in Alzheimer's disease and Dementia. He carries out multidisciplinary research, doing studies in Genetics and Allele.
Disease is often connected to Frontotemporal dementia in his work. Sebastiaan Engelborghs regularly ties together related areas like Disease in his Frontotemporal dementia studies. Sebastiaan Engelborghs performs integrative study on Internal medicine and Oncology. In his works, he performs multidisciplinary study on Oncology and Internal medicine. He incorporates Dementia and Alzheimer's disease in his studies. While working in this field, Sebastiaan Engelborghs studies both Alzheimer's disease and Dementia. He frequently studies issues relating to Cerebrospinal fluid and Pathology. His research on Cerebrospinal fluid often connects related topics like Pathology. He conducts interdisciplinary study in the fields of Genetics and Mutation through his works.
The study of Cognitive decline and Frontotemporal dementia are components of his Dementia research. Many of his studies on Neuroscience apply to Cerebrospinal fluid, Alzheimer's Disease Neuroimaging Initiative and Neuroimaging as well. As part of his studies on Cerebrospinal fluid, he frequently links adjacent subjects like Neuroscience. He integrates many fields, such as Magnetic resonance imaging, Radiology and Neuroimaging, in his works. Sebastiaan Engelborghs performs integrative study on Radiology and Magnetic resonance imaging in his works. In most of his Disease studies, his work intersects topics such as Neurodegeneration. His work in Neurodegeneration is not limited to one particular discipline; it also encompasses Disease. Pathology and Cognitive decline are frequently intertwined in his study. He performs multidisciplinary study in the fields of Internal medicine and Endocrinology via his papers.
Research on Dementia with Lewy bodies and Cognitive decline is a part of his Dementia study. Much of his study explores Cognitive decline relationship to Disease. His Dementia with Lewy bodies research extends to the thematically linked field of Disease. Sebastiaan Engelborghs performs multidisciplinary study in the fields of Pathology and Neurology via his papers. In his articles, he combines various disciplines, including Neurology and Dementia. Many of his studies on Biomarker involve topics that are commonly interrelated, such as Biochemistry. His Biochemistry study frequently links to adjacent areas such as Biomarker. Sebastiaan Engelborghs undertakes multidisciplinary studies into Genetics and Computational biology in his work. He performs integrative study on Computational biology and Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims.
Nature Genetics (2009)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))
D Harold;R Abraham;P Hollingworth;R Sims.
Nature Genetics (2013)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts;Ilse Gijselinck;Julie van der Zee;Sebastiaan Engelborghs.
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study.
Ilse Gijselinck;Tim Van Langenhove;Julie van der Zee;Kristel Sleegers.
Lancet Neurology (2012)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E Genin;D Hannequin;D Wallon;K Sleegers.
Molecular Psychiatry (2011)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Gernot Kleinberger;Yoshinori Yamanishi;Marc Suárez-Calvet;Eva Czirr.
Science Translational Medicine (2014)
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman.
Nature Genetics (2011)
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Geert De Meyer;Fred Shapiro;Hugo Vanderstichele;Eugeen Vanmechelen.
JAMA Neurology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: